Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.medicaps.com | |
Market Cap | 52.62 Cr. | |
Enterprise Value(EV) | 51.92 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 5.03 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 8.48 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 25.90 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 95.25 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 0.45 | Calculated using Price: 42.70 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.25 Cr. | 12,469,956 Shares |
FaceValue | 10 | |
Company Profile | ||
Medi-Caps incorporated in 1986 is a flagship company of Medi-Caps Group, is one of the largest manufacturer of empty hard gelatin capsules in terms of manufacturing capacity as well as market capitalization in India. Medi-Caps entered the highly competitive market with a team of dedicated professionals, duly supported by competent individuals in every aspect of operation. |
1 Day |
|
-2.29% |
1 Week |
|
-1.61% |
1 Month |
|
-6.15% |
3 Month |
|
-6.67% |
6 Month |
|
-18.82% |
1 Year |
|
-40.82% |
2 Year |
|
+92.78% |
5 Year |
|
+47.24% |
10 Year |
|
+265.58% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | -2.20 | -2.50 | 1.06 | 1.60 | 1.28 | 5.80 | -6.27 | 11.49 | 9.09 | |
Return on Capital Employed (%) | 0.49 | -0.69 | 1.80 | 2.12 | 1.61 | 6.06 | -6.13 | 11.59 | 9.20 | |
Return on Assets (%) | -1.74 | -2.15 | 0.95 | 1.44 | 1.16 | 5.19 | -5.80 | 10.71 | 8.19 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 83 | 81 | 82 | 89 | 90 | 96 | 91 | 105 | 116 | 119 | |
Non Curr. Liab. | 10 | 2 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | |
Curr. Liab. | 6 | 6 | 9 | 7 | 9 | 9 | 3 | 9 | 13 | 9 | |
Minority Int. | 3 | ||||||||||
Equity & Liab. | 102 | 89 | 93 | 97 | 101 | 107 | 95 | 115 | 130 | 129 | |
Non Curr. Assets | 65 | 62 | 61 | 64 | 64 | 65 | 62 | 62 | 64 | 65 | |
Curr. Assets | 37 | 27 | 32 | 33 | 37 | 42 | 33 | 53 | 67 | 64 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 102 | 89 | 93 | 97 | 101 | 107 | 95 | 115 | 130 | 129 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 37 | 36 | 43 | 44 | 50 | 52 | 43 | 59 | 70 | 63 | |
Other Income | 1 | 1 | 1 | 2 | 1 | 3 | 3 | 1 | 2 | 3 | |
Total Income | 39 | 37 | 44 | 46 | 51 | 55 | 46 | 59 | 72 | 66 | |
Total Expenditure | -36 | -36 | -40 | -42 | -48 | -47 | -50 | -46 | -60 | -58 | |
PBIDT | 3 | 1 | 3 | 4 | 3 | 7 | -4 | 13 | 12 | 8 | |
Interest | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Depreciation | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | |
Taxation | -1 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Items | |||||||||||
PAT | -2 | -2 | 1 | 1 | 1 | 5 | -6 | 11 | 10 | 6 | |
Minority Interest | 0 | ||||||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | -1 | -2 | 1 | 1 | 1 | 5 | -6 | 11 | 10 | 6 | |
Adjusted EPS | -1 | -2 | 1 | 1 | 1 | 4 | -5 | 9 | 8 | 5 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | -14 | -2 | 7 | 3 | 4 | 4 | 6 | 5 | 15 | 7 | |
Cash Fr. Inv. | 6 | 2 | -7 | -1 | 3 | -4 | -6 | -6 | -10 | -4 | |
Cash Fr. Finan. | 7 | -1 | -6 | 0 | 0 | 0 | 0 | ||||
Net Change | -1 | 0 | 0 | 0 | 1 | 0 | 0 | -1 | 6 | 3 | |
Cash & Cash Eqvt | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 7 | 10 |
Mon, 09 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 In accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulation 2018 for the quarter and Nine month ended 31st December 2022 please find enclosed herewith the certificate received from the Registrar and Share Transfer Agent of the company Ankit Consultancy Private Limited. |
Thu, 29 Dec 2022
Closure of Trading Window Pursuant to SEBI (Prohibition of Insider Trading) Regulation 2015 as amended from time to time read with BSE circular No. LIST/COMP/01/2019-20 dated 2nd April 2019 the window for trading in the shares of the Company shall remain closed from 1st January 2023 till completion of 48 hours after the declaration of the Unaudited Standalone and Consolidated Financial Results for the quarter & nine month ended on 31st December 2022 to the Stock Exchange. |
Tue, 20 Dec 2022
Clarification Letter In Respect Of Discrepancy In Standalone & Consolidated Cash Flow Statement For The Half Year Ended 30.09.2022. With reference to the Subject captioned above we are in receipt of an email from your good office on 19th December 2022 for discrepancy observed in the Standalone & Consolidated Cash Flow Statement for the half year ended 30.09.2022. It may please be noted that due to typographical error earlier closing of cash & cash equivalent of 30th September 2021 was mentioned in opening of 30th September 2022 instead of Closing of 31st March 2022 in standalone & Consolidated Cash flow statement however later on corrected printout was taken but inadvertently wrong cash flow statement was submitted in PDF file. Copy of updated cash flow statement is enclosed for your reference. Further please note that due to aforesaid discrepancy there will be no impact on financial result for quarter and half year ended 30th September 2022. |
Mon, 30 Jan 2023 |
|
|
|
|
|